鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/28 | 2,365 | 2,380 | 2,326 | 2,328 | -29 | -1.2% | 34,900 |
2019/02/27 | 2,360 | 2,381 | 2,331 | 2,357 | -12 | -0.5% | 50,200 |
2019/02/26 | 2,375 | 2,386 | 2,340 | 2,369 | -17 | -0.7% | 19,000 |
2019/02/25 | 2,380 | 2,394 | 2,354 | 2,386 | +26 | +1.1% | 27,300 |
2019/02/22 | 2,386 | 2,386 | 2,302 | 2,360 | -32 | -1.3% | 38,700 |
2019/02/21 | 2,437 | 2,446 | 2,357 | 2,392 | +55 | +2.4% | 61,700 |
2019/02/20 | 2,305 | 2,337 | 2,285 | 2,337 | +25 | +1.1% | 24,300 |
2019/02/19 | 2,290 | 2,317 | 2,261 | 2,312 | +55 | +2.4% | 42,300 |
2019/02/18 | 2,230 | 2,292 | 2,230 | 2,257 | +47 | +2.1% | 65,100 |
2019/02/15 | 2,166 | 2,211 | 2,153 | 2,210 | +8 | +0.4% | 29,000 |
2019/02/14 | 2,186 | 2,213 | 2,142 | 2,202 | +2 | +0.1% | 29,600 |
2019/02/13 | 2,235 | 2,235 | 2,182 | 2,200 | -8 | -0.4% | 43,600 |
2019/02/12 | 2,173 | 2,209 | 2,156 | 2,208 | +57 | +2.6% | 65,000 |
2019/02/08 | 2,090 | 2,177 | 2,080 | 2,151 | -4 | -0.2% | 92,600 |
2019/02/07 | 2,225 | 2,235 | 2,132 | 2,155 | -317 | -12.8% | 223,500 |
2019/02/06 | 2,436 | 2,532 | 2,436 | 2,472 | +15 | +0.6% | 50,300 |
2019/02/05 | 2,506 | 2,525 | 2,431 | 2,457 | -49 | -2% | 35,700 |
2019/02/04 | 2,423 | 2,507 | 2,423 | 2,506 | +93 | +3.9% | 27,300 |
2019/02/01 | 2,386 | 2,427 | 2,383 | 2,413 | +14 | +0.6% | 25,800 |
2019/01/31 | 2,392 | 2,413 | 2,388 | 2,399 | +11 | +0.5% | 31,600 |
2019/01/30 | 2,402 | 2,409 | 2,386 | 2,388 | -42 | -1.7% | 65,400 |
2019/01/29 | 2,409 | 2,436 | 2,393 | 2,430 | +21 | +0.9% | 27,800 |
2019/01/28 | 2,448 | 2,449 | 2,402 | 2,409 | -33 | -1.4% | 34,200 |
2019/01/25 | 2,493 | 2,503 | 2,436 | 2,442 | +33 | +1.4% | 51,900 |
2019/01/24 | 2,401 | 2,443 | 2,397 | 2,409 | -8 | -0.3% | 32,500 |
2019/01/23 | 2,453 | 2,460 | 2,400 | 2,417 | -59 | -2.4% | 45,400 |
2019/01/22 | 2,499 | 2,517 | 2,446 | 2,476 | -10 | -0.4% | 24,000 |
2019/01/21 | 2,484 | 2,519 | 2,483 | 2,486 | +15 | +0.6% | 21,000 |
2019/01/18 | 2,467 | 2,507 | 2,467 | 2,471 | +5 | +0.2% | 14,800 |
2019/01/17 | 2,506 | 2,517 | 2,460 | 2,466 | -38 | -1.5% | 33,800 |
2019/01/16 | 2,533 | 2,533 | 2,494 | 2,504 | -18 | -0.7% | 24,900 |
2019/01/15 | 2,488 | 2,596 | 2,486 | 2,522 | -7 | -0.3% | 27,600 |
2019/01/11 | 2,530 | 2,534 | 2,472 | 2,529 | -21 | -0.8% | 36,900 |
2019/01/10 | 2,550 | 2,566 | 2,529 | 2,550 | ±0 | ±0% | 22,400 |
2019/01/09 | 2,521 | 2,572 | 2,514 | 2,550 | +29 | +1.2% | 41,800 |
2019/01/08 | 2,491 | 2,545 | 2,474 | 2,521 | +10 | +0.4% | 41,100 |
2019/01/07 | 2,562 | 2,588 | 2,495 | 2,511 | +24 | +1% | 37,400 |
2019/01/04 | 2,408 | 2,493 | 2,385 | 2,487 | +54 | +2.2% | 37,700 |
2018/12/28 | 2,498 | 2,499 | 2,415 | 2,433 | -67 | -2.7% | 16,000 |
2018/12/27 | 2,467 | 2,500 | 2,407 | 2,500 | +95 | +4% | 46,100 |
2018/12/26 | 2,361 | 2,447 | 2,361 | 2,405 | +28 | +1.2% | 50,600 |
2018/12/25 | 2,439 | 2,439 | 2,365 | 2,377 | -112 | -4.5% | 43,600 |
2018/12/21 | 2,543 | 2,543 | 2,417 | 2,489 | -55 | -2.2% | 50,300 |
2018/12/20 | 2,602 | 2,627 | 2,543 | 2,544 | -85 | -3.2% | 43,700 |
2018/12/19 | 2,570 | 2,685 | 2,537 | 2,629 | +29 | +1.1% | 72,800 |
2018/12/18 | 2,600 | 2,631 | 2,562 | 2,600 | -44 | -1.7% | 46,900 |
2018/12/17 | 2,635 | 2,698 | 2,623 | 2,644 | -18 | -0.7% | 48,200 |
2018/12/14 | 2,685 | 2,685 | 2,642 | 2,662 | -20 | -0.7% | 51,300 |
2018/12/13 | 2,600 | 2,719 | 2,600 | 2,682 | +92 | +3.6% | 95,800 |
2018/12/12 | 2,499 | 2,620 | 2,483 | 2,590 | +121 | +4.9% | 98,800 |
1401~
1450
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム